Weaver Gregory L
CIK 0001251779
Former EVP, CFO, & DirectorDirector
Filings
13
Latest Apr 1, 2026
Issuers covered
3
Showing
13 of 13
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 20% | -4.3% | -9.6% | +18.8% | -13.8% |
| 90 days | 4 | 25% | -14.4% | -17.1% | +25.8% | -49.2% |
| 180 days | 3 | 0% | -59.0% | -27.3% | -25.0% | -124.6% |
| 365 days | 3 | 33% | -42.6% | -32.7% | +15.6% | -110.8% |
Issuers
Companies where Weaver Gregory L has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALT | Altimmune, Inc. | 7 | Apr 1, 2026 |
| ATOS | Atossa Therapeutics, Inc. | 5 | Nov 17, 2023 |
| ATAI | Atai Life Sciences N.V. | 1 | Mar 4, 2022 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|